Related Experiment Video
Updated: Aug 7, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Iris atrophy after administration of Dexycu: Additional evidence and possible mechanism for a rare complication
Azraa Ayesha1, Ryan T Wallace2, Anthony P Mai3
1University of Utah School of Medicine, USA.
Purpose:
To report the observation of iris atrophy with the use of Dexycu in cataract surgery and describe a possible mechanism for this complication.
Observations:
Between 2020 and 2021, 2 patients underwent cataract surgery procedures with the use of Dexycu and experienced iris atrophy. The first case of iris atrophy was discovered by 6-month follow-up and the second case by 2-month follow-up. The timing and nature of this complication possibly represent more than steroid-induced hypopigmentation.
Conclusions And Importance:
This publication adds further evidence of iris atrophy and a proposed mechanism associated with the use of Dexycu. Surgeons should be aware of this complication, especially when operating on eyes with dark irides.
More Related Videos
08:04A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
Published on: January 24, 2020
07:43Establishment of a Severe Dry Eye Model Using Complete Dacryoadenectomy in Rabbits
Published on: January 8, 2020
Related Concept Videos
Radiological Investigation I: X-ray and CT
Imaging Studies for Cardiovascular System V: CT
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiac Catheterization I: Pre-Procedure Overview
Rheumatic Heart Disease I: Introduction
Heart Failure Drugs: Inotropic Agents